These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 10603388)

  • 21. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I
    Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogen.
    Hoft DF; Eickhoff CS
    Infect Immun; 2005 Aug; 73(8):4934-40. PubMed ID: 16041007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.
    Muñoz-Fernández MA; Fernández MA; Fresno M
    Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Driving of Immune Response by Th1 Adjuvants in Immunization of Mice with Trypanosoma cruzi marinkellei Elicits a Controversial Infection Control.
    Nascentes GA; Hernández CG; Rabelo RA; Coelho RF; Morais FR; Marques T; Batista LR; Meira WS; Oliveira CJ; Lages Silva E; Ramírez LE
    Vector Borne Zoonotic Dis; 2016 May; 16(5):317-25. PubMed ID: 26959861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene gun-mediated delivery of an interleukin-12 expression plasmid protects against infections with the intracellular protozoan parasites Leishmania major and Trypanosoma cruzi in mice.
    Sakai T; Hisaeda H; Nakano Y; Ishikawa H; Maekawa Y; Ishii K; Nitta Y; Miyazaki J; Himeno K
    Immunology; 2000 Apr; 99(4):615-24. PubMed ID: 10792510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
    Hoft DF; Lynch RG; Kirchhoff LV
    J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The surface protein superfamily of Trypanosoma cruzi stimulates a polarized Th1 response that becomes anergic.
    Millar AE; Wleklinski-Lee M; Kahn SJ
    J Immunol; 1999 May; 162(10):6092-9. PubMed ID: 10229851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease.
    Brener Z; Gazzinelli RT
    Int Arch Allergy Immunol; 1997 Oct; 114(2):103-10. PubMed ID: 9338602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastric invasion by Trypanosoma cruzi and induction of protective mucosal immune responses.
    Hoft DF; Farrar PL; Kratz-Owens K; Shaffer D
    Infect Immun; 1996 Sep; 64(9):3800-10. PubMed ID: 8751932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic cells devoid of IL-10 induce protective immunity against the protozoan parasite Trypanosoma cruzi.
    Alba Soto CD; Solana ME; Poncini CV; Pino-Martinez AM; Tekiel V; González-Cappa SM
    Vaccine; 2010 Oct; 28(46):7407-13. PubMed ID: 20850535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of Effective Immunity against Trypanosoma cruzi.
    Williams T; Guerrero-Ros I; Ma Y; Matos Dos Santos F; Scherer PE; Gordillo R; Horta A; Macian F; Weiss LM; Huang H
    Infect Immun; 2020 Mar; 88(4):. PubMed ID: 31907197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P47phox-/- mice are compromised in expansion and activation of CD8+ T cells and susceptible to Trypanosoma cruzi infection.
    Dhiman M; Garg NJ
    PLoS Pathog; 2014 Dec; 10(12):e1004516. PubMed ID: 25474113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the dynamics of infiltrating CD4(+) T cell subsets in the heart during experimental Trypanosoma cruzi infection.
    Sanoja C; Carbajosa S; Fresno M; Gironès N
    PLoS One; 2013; 8(6):e65820. PubMed ID: 23776551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infection with Trypanosoma cruzi selectively upregulates B7-2 molecules on macrophages and enhances their costimulatory activity.
    Frosch S; Küntzlin D; Fleischer B
    Infect Immun; 1997 Mar; 65(3):971-7. PubMed ID: 9038305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination.
    de Alencar BC; Persechini PM; Haolla FA; de Oliveira G; Silverio JC; Lannes-Vieira J; Machado AV; Gazzinelli RT; Bruna-Romero O; Rodrigues MM
    Infect Immun; 2009 Oct; 77(10):4383-95. PubMed ID: 19651871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase.
    Hölscher C; Köhler G; Müller U; Mossmann H; Schaub GA; Brombacher F
    Infect Immun; 1998 Mar; 66(3):1208-15. PubMed ID: 9488415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenge of chronically infected mice with homologous trypanosoma cruzi parasites enhances the immune response but does not modify cardiopathy: implications for the design of a therapeutic vaccine.
    Rosas-Jorquera CE; Sardinha LR; Pretel FD; Bombeiro AL; D'Império Lima MR; Alvarez JM
    Clin Vaccine Immunol; 2013 Feb; 20(2):248-54. PubMed ID: 23254299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
    Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM
    J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
    Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
    Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.